Date: ______ Patient: Last name: First name: ‘. How would you assess your pain now, at this moment? 0. 1. 2. 3. 4. 5. 6. 7. 8. 9. Please mark your main area. 16 Sep Background: The PainDETECT Questionnaire (PD-Q) is a screening tool for. Neuropathic Pain (NeP). A cut-off value of ≥ 13 indicates the. With the painDETECT Questionnaire (PDQ), the rheumatologist may have an easily applicable and prognostic useful tool to judge the possible treatment.
|Published (Last):||17 December 2013|
|PDF File Size:||8.36 Mb|
|ePub File Size:||17.86 Mb|
|Price:||Free* [*Free Regsitration Required]|
Log in via Institution. Test-retest of computerized health status questionnaires frequently used in the monitoring of knee osteoarthritis: Temporal summation of pain and ultrasound Doppler activity as paimdetect of treatment response in patients with rheumatoid arthritis: J Int Med Res ; All images will be assessed blinded and paired by the same senior radiologist MB. Self-reported somatosensory symptoms of neuropathic pain in fibromyalgia and chronic widespread pain correlate with tender point count and pressure-pain thresholds.
Finally, this study can help to set focus on the fact quesitonnaire clinical pain management in patients with RA may benefit from a shift from symptom-based approaches to an approach targeting underlying pain mechanisms.
We primarily aim to describe the relationship between central sensitisation and treatment outcome. With the painDETECT Questionnaire PDQthe rheumatologist may have an easily applicable and prognostic useful tool to judge the possible treatment outcome of anti-inflammatory treatment.
Fibromyalgia and neuropathic pain—differences and similarities.
painDETECT Questionnaire (PD-Q)
Psychophysical and functional imaging evidence supporting the presence of central sensitization in a cohort of osteoarthritis patients. Introduction Rheumatoid arthritis RA is a condition characterised by synovial inflammation, joint destruction and pain. Evidence for treating rheumatoid arthritis to target: Furthermore, the study will contribute to the field within DCE-MRI by producing knowledge concerning detectable change in the inflammation load in a heterogeneous RA population as seen in daily rheumatological care, thus having a potential of generalisable interpretation.
Signed informed consent is obtained from all participants. As low back pain LBP patients constitute an important subgroup of chronic pain patients, we addressed the following issues: All information is recorded and all examinations are carried out at a single centre. Log in using your username and password For personal accounts OR managers of institutional accounts. This study is designed as an exploratory study.
Simple, patient-based, easy-to-use screening questionnaires can determine the prevalence of neuropathic pain components both in individual LBP patients and in heterogeneous cohorts of such patients. In case of no difference, the dominant hand is chosen. When evaluating the data distributions of the continuous outcomes, we will use visual inspections of the studentised residuals to suggest whether the assumption of normality is reasonable.
Generate a file for use with external citation management software.
Supplemental Content Full text links. Log In More Log in via Institution.
View inline View popup. As described elsewhere, the response according to the European League Against Rheumatism EULAR response criteria, transition questionnaire score, and changes in the following variables will also be explored: Arthritis Res Ther ; Forgot your user name or password?
Ann Rheum Dis ; Ultrasound Doppler measurements predict success of treatment with anti-TNF-alpha drug in patients with rheumatoid arthritis: In contrast to RA patients with chronic pain states who report constant high tender joint count, and high global health assessments and questionnairw analog scale VAS pain score, another subset of RA patients indicate good treatment effect on self-reports despite disease activity according to, for example, imaging.
In contrast, other patients report good treatment response, although imaging shows signs of inflammation, which could indicate a possible enhancement of descending pain inhibitory mechanisms. This study, including the amendmentsandhas been approved by The Capital region of Denmark’s Ethics Committee with the identification number H Despite better control of questionnairr, some patients still report pain as a significant concern, even when being in clinical remission.
Ethics and dissemination This study aims at supporting rheumatologists to define strategies to reach optimal treatment outcomes in patients with RA based on chronic pain prognostics. Therapies for active rheumatoid arthritis after methotrexate failure.
PD-Q – painDETECT Questionnaire
Pain ; 3 Suppl: Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: A detailed description of patient demographics and all other patient reported outcomes has been published elsewhere by the coauthor AWC.
BMC Neurol ; The paindetetc to initiate or change to biological treatment is taken collectively by senior rheumatologists at the department’s biologics conference where representatives of the study are also present. Exclusion criteria, treatment responsibility and the drop out procedure are thoroughly described elsewhere by the coauthor AWC. Search for this keyword. Simultaneously with the intravenous injection of 0. Other known inflammatory rheumatic diseases 5.
However, with the planned study design, we will also be able to describe a possible subgroup of patients with reported low tender joint count, and low global health assessment and VAS pain score, but having inflammatory activity on MRI. Gac Sanit ;